Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 1060469 in Healthy Subjects and Patients with Asthma
NCT02126865Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2014
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of BI 1060469 in asthma (4 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Percentage of subjects with drug-related adverse events. Started May 2014; status: completed.
02
Drugs
BI 1060469
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02126865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02126865.